Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged

Authors: Gomez-Veiga, Francisco, Szmulewitz, Russell Z., Holzbeierlein, Jeffrey, Azad, Arun A., Iguchi, Taro, Villers, Arnauld, Alcaraz, Antonio, Alekseev, Boris, Shore, Neal D., Rosbrook, Brad, Zohren, Fabian, Ma, Jie, Haas, Gabriel P., Stenzl, Arnulf, Armstrong, Andrew J.

Source: In European Urology Oncology August 2024 7(4):860-869

The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES

Authors: Armstrong, Andrew J., Iguchi, Taro, Azad, Arun A., Villers, Arnauld, Alekseev, Boris, Petrylak, Daniel P., Szmulewitz, Russell Z., Alcaraz, Antonio, Shore, Neal D., Holzbeierlein, Jeffrey, Gomez-Veiga, Francisco, Rosbrook, Brad, Zohren, Fabian, Haas, Gabriel P., Gourgiotti, Georgia, El-Chaar, Nader, Stenzl, Arnulf

Source: In European Urology August 2023 84(2):229-241

Summary of the clinical practice guideline for the management of urinary stones, third edition.

Authors: Miyazawa, Katsuhito, Yamaguchi, Satoshi, Iguchi, Taro, Chikazawa, Ippei, Yasui, Takahiro, Takahashi, Satoru, Hinotsu, Shiro, Akakura, Koichiro, Iida, Shizuka, Ishito, Noritaka, Inoue, Takaaki, Kohjimoto, Yasuo, Sakamoto, Shinichi, Sato, Yoshikazu, Takazawa, Ryoji, Takayama, Tatsuya, Tsujihata, Masao, Naya, Yukio, Hamamoto, Shuzo, Masai, Motoyuki

Source: International Journal of Urology; May2025, Vol. 32 Issue 5, p462-474, 13p

Subject Terms: URINARY calculi, TREATMENT effectiveness, MEDICAL decision making, EVIDENCE-based medicine, MEDICAL protocols

Geographic Terms: JAPAN

Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study

Authors: Stenzl, Arnulf, Dunshee, Curtis, De Giorgi, Ugo, Alekseev, Boris, Iguchi, Taro, Szmulewitz, Russell Z., Flaig, Thomas W., Tombal, Bertrand, Morlock, Robert, Ivanescu, Cristina, Ramaswamy, Krishnan, Saad, Fred, Armstrong, Andrew J.

Source: In European Urology October 2020 78(4):603-614

Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer

Authors: Takeyama, Yuji, Kato, Minoru, Tamada, Satoshi, Azuma, Yukari, Shimizu, Yasuomi, Iguchi, Taro, Yamasaki, Takeshi, Gi, Min, Wanibuchi, Hideki, Nakatani, Tatsuya

Source: In Cancer Letters 1 June 2020 479:89-99

Kamikihito improves cancer-related fatigue by restoring balance between the sympathetic and parasympathetic nervous systems

Authors: Tamada, Satoshi, Ebisu, Kyoko, Yasuda, Sayaka, Kato, Minoru, Ninomiya, Noriko, Yamasaki, Takeshi, Iguchi, Taro, Nakatani, Tatsuya, Watanabe, Yasuyoshi

Source: In Prostate International June 2018 6(2):55-60

Kamikihito improves cancer‐related fatigue in castration‐resistant prostate cancer patients receiving enzalutamide: Multidimensional approach including metabolomics analysis.

Authors: Tamada, Satoshi¹ (AUTHOR) satoshitamada@osaka.med.or.jp, Iguchi, Taro² (AUTHOR), Kato, Minoru³ (AUTHOR), Yamasaki, Takeshi³ (AUTHOR), Tsuchiya, Naoko⁴ (AUTHOR), Ohbuchi, Katsuya⁴ (AUTHOR), Shimobori, Chika⁴ (AUTHOR), Nojima, Junzo⁵ (AUTHOR), Yasuda, Sayaka³ (AUTHOR), Ebisu, Kyoko⁶ (AUTHOR), Watanabe, Yasuyoshi⁶ (AUTHOR)

Source: Traditional & Kampo Medicine. Dec2021, Vol. 8 Issue 3, p204-210. 7p.

Subject Terms: *CASTRATION-resistant prostate cancer, *PROSTATE cancer patients, *CANCER fatigue, *CENTER for Epidemiologic Studies Depression Scale, *METABOLOMICS

Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone‐sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study.

Authors: Iguchi, Taro¹ (AUTHOR) taro@msic.med.osaka-cu.ac.jp, Kimura, Go² (AUTHOR), Fukasawa, Satoshi³ (AUTHOR), Suzuki, Hiroyoshi⁴ (AUTHOR), Uemura, Hiroji⁵ (AUTHOR), Nishimura, Kazuo⁶ (AUTHOR), Matsumoto, Hiroaki⁷ (AUTHOR), Yokomizo, Akira⁸ (AUTHOR), Armstrong, Andrew J⁹ (AUTHOR), Rosbrook, Brad¹⁰ (AUTHOR), Sugg, Jennifer¹¹ (AUTHOR), Baron, Benoit¹² (AUTHOR), Chen, Lucy¹¹ (AUTHOR), Kunieda, Futoshi¹¹ (AUTHOR), Stenzl, Arnulf¹³ (AUTHOR)

Source: International Journal of Urology. Jul2021, Vol. 28 Issue 7, p765-773. 9p.

Subject Terms: *ANDROGEN deprivation therapy, *PROSTATE cancer, *JAPANESE people, *OVERALL survival, *SUBGROUP analysis (Experimental design), *PROSTATE-specific antigen

Geographic Terms: JAPAN

A study of the association between enzalutamide blood concentrations and adverse events in patients with castration-resistant prostate cancer.

Authors: Iguchi, Taro¹ (AUTHOR), Kato, MInoru² (AUTHOR), Hirayama, Yukiyoshi³ (AUTHOR), Yamasaki, Takeshi⁴ (AUTHOR), Yasuda, Sayaka⁵ (AUTHOR), Morita, Nobuyo⁶ (AUTHOR), Chikazawa, Ippei⁶ (AUTHOR), Fukushima, Wakaba⁷ (AUTHOR), Tamada, Satoshi⁸ (AUTHOR), Miyazawa, Katsuhito⁶ (AUTHOR)

Source: Journal of Clinical Oncology. 2024 Supplement 4, Vol. 42, p102-102. 235p.

Glucose intolerance in renal transplant recipients is associated with increased urinary albumin excretion

Authors: Uchida, Junji, Iwai, Tomoaki, Kuwabara, Nobuyuki, Machida, Yuichi, Iguchi, Taro, Naganuma, Toshihide, Kumada, Norihiko, Kawashima, Hidenori, Nakatani, Tatsuya

Source: In Transplant Immunology 2011 24(4):241-245

O2-19-6 - Kamikihito improves cancer related fatigue by restoring balance between the autonomic nervous system

Authors: Tamada, Satoshi, Ebisu, Kyoko, Yasuda, Sayaka, Iguchi, Taro, Nakatani, Tatsuya, Watanabe, Yasuyoshi

Source: In Annals of Oncology October 2017 28 Supplement 9:ix90-ix90

Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study).

Authors: Iguchi, Taro¹ (AUTHOR) taro@msic.med.osaka-cu.ac.jp, Tamada, Satoshi¹ (AUTHOR) s-tamada@med.osaka-cu.ac.jp, Kato, Minoru¹ (AUTHOR) m1112173@med.osaka-cu.ac.jp, Yasuda, Sayaka¹ (AUTHOR) yasudas@med.osaka-cu.ac.jp, Yamasaki, Takeshi¹ (AUTHOR) tysy-y@mx5.canvas.ne.jp, Nakatani, Tatsuya¹ (AUTHOR) nakatani@med.osaka-cu.ac.jp

Source: BMC Cancer. 4/11/2019, Vol. 19 Issue 1, p1-7. 7p. 1 Diagram, 1 Chart.

Subject Terms: *CASTRATION-resistant prostate cancer, *FLUTAMIDE, *ANDROGEN receptors, *PROSTATE-specific antigen

Company/Entity: UNIVERSITY of Colorado Hospital

Oncological outcomes classified according to metastatic lesions in the era of molecular targeted drugs for metastatic renal cancer.

Authors: Shimizu, Yasuomi¹, Iguchi, Taro¹, Tamada, Satoshi¹ s-tamada@med.osaka-cu.ac.jp, Yasuda, Sayaka¹, Kato, Minoru¹, Ninomiya, Noriko¹, Yamasaki, Takeshi¹, Nakatani, Tatsuya¹

Source: Molecular & Clinical Oncology. 2018, Vol. 8 Issue 6, p791-796. 6p.

Subject Terms: *RENAL cancer treatment, *RENAL cancer patients, *TARGETED drug delivery

P3-6-12 - Short-term outcome of enzalutamide in Japanese patients with castration-resistant prostate cancer

Authors: Tamada, Satoshi, Iguchi, Taro, Tachibana, Hirokazu, Nakatani, Tatsuya

Source: In Annals of Oncology November 2015 26 Supplement 7:vii145-vii145

Outcomes of indwelling metallic stents for malignant extrinsic ureteral obstruction.

Authors: Asakawa, Jumpei¹, Iguchi, Taro¹, Tamada, Satoshi¹, Ninomiya, Noriko¹, Kato, Minoru¹, Yamasaki, Takeshi¹, Nakatani, Tatsuya¹

Source: International Journal of Urology. Mar2018, Vol. 25 Issue 3, p258-262. 5p.

Subject Terms: *HEALTH outcome assessment, *POLYMERIC composites, *METAL fiber-reinforced polymeric composites, *SURGICAL stents, *RESONANCE

The impact of enzalutamide on quality of life in men with metastatic hormone‐sensitive prostate cancer based on prior therapy, risk, and symptom subgroups.

Authors: Stenzl, Arnulf, Szmulewitz, Russell Z., Petrylak, Daniel, Holzbeierlein, Jeffrey, Villers, Arnauld, Azad, Arun, Alcaraz, Antonio, Alekseev, Boris, Iguchi, Taro, Shore, Neal D., Gomez‐Veiga, Francisco, Ivanescu, Cristina, Rosbrook, Brad, Ramaswamy, Krishnan, Ganguli, Arijit, Haas, Gabriel P., Armstrong, Andrew J.

Source: Prostate; Sep2022, Vol. 82 Issue 13, p1237-1247, 11p

Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Authors: Armstrong, Andrew J¹ (AUTHOR), Azad, Arun A^2,3 (AUTHOR), Iguchi, Taro⁴ (AUTHOR), Szmulewitz, Russell Z⁵ (AUTHOR), Petrylak, Daniel P⁶ (AUTHOR), Holzbeierlein, Jeffrey⁷ (AUTHOR), Villers, Arnauld⁸ (AUTHOR), Alcaraz, Antonio⁹ (AUTHOR), Alekseev, Boris¹⁰ (AUTHOR), Shore, Neal D¹¹ (AUTHOR), Gomez-Veiga, Francisco^12,13 (AUTHOR), Rosbrook, Brad¹⁴ (AUTHOR), Zohren, Fabian¹⁴ (AUTHOR), Yamada, Shunsuke¹⁵ (AUTHOR), Haas, Gabriel P¹⁵ (AUTHOR), Stenzl, Arnulf¹⁶ (AUTHOR)

Source: Journal of Clinical Oncology. 5/20/2022, Vol. 40 Issue 15, p1616-1622. 7p.

Descriptive study on burden and communication of fatigue among castration-resistant prostate cancer patients in Japan.

Authors: Iguchi, Taro¹ (AUTHOR), Nakamura, Yusuke² (AUTHOR), Akiyama, Takeshi³ (AUTHOR), Chand, Krishant³ (AUTHOR), Yu, Eric³ (AUTHOR)

Source: Current Medical Research & Opinion. Mar 2022, Vol. 38 Issue 3, p417-426. 10p.

Subject Terms: *CASTRATION-resistant prostate cancer, *PROSTATE cancer patients, *FATIGUE (Physiology), *PATIENTS' attitudes, *JAPANESE people, *PHYSICIAN-patient relations

Geographic Terms: JAPAN

Association of MnSOD AA Genotype with the Progression of Prostate Cancer.

Authors: Iguchi, Taro^1,2 taro@msic.med.osaka-cu.ac.jp, Wang, Ching Y.¹, Delongchamps, Nicolas B.^1,3, Kato, Minoru², Tamada, Satoshi², Yamasaki, Takeshi², de la Roza, Gustavo⁴, Nakatani, Tatsuya², Haas, Gabriel P.¹

Source: PLoS ONE. 7/6/2015, Vol. 10 Issue 7, p1-8. 8p.

Subject Terms: *MANGANESE compounds, *PROSTATE cancer, *DISEASE progression, *GENETIC polymorphisms, *POLYMERASE chain reaction

Edaravone Inhibits Acute Renal Injury and Cyst Formation in Cisplatin-Treated Rat Kidney.

Authors: Iguchi, Taro^1,2, Nishikawa, Manabu¹, Chang, Baojun¹, Muroya, Osuke¹, Sato, Eisuke F.¹, Nakatani, Tatsuya², Inoue, Masayasu¹ inoue@med.osaka-cu.ac.jp

Source: Free Radical Research. Apr2004, Vol. 38 Issue 4, p333-341. 9p. 2 Color Photographs, 1 Black and White Photograph, 4 Graphs.

Subject Terms: *CISPLATIN, *NEPHROTOXICOLOGY, *CYSTS (Pathology), *MITOCHONDRIA, *FREE radicals, *ACUTE kidney failure, *LABORATORY rats